TG Therapeutics società ha sostenuto
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. leggi di più
HR or Marketing? Claim Your Free Employer Account
Treat your staff how you would like to be treated.
Perché ti senti sottovalutato e che cosa ti farebbe sentire meglio con il tuo compenso?
I was lead to believe to be apart of something great. Working on tasks to the best of my abilities then realizing they were just using me as much as possible.
Other Employee Reviews for TG Therapeutics
×